These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23167420)

  • 1. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
    Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
    Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
    Wei X; Chen D; Lv T
    Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
    Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
    Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D; Jiang H; Gu Q; Zhang D; Li Z
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between the XRCC1 polymorphisms and clinical outcomes of advanced NSCLC treated with platinum-based chemotherapy: a meta-analysis based on the PRISMA statement.
    Li DJ; Xiao D
    BMC Cancer; 2017 Jul; 17(1):501. PubMed ID: 28743242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the XRCC1 Arg194Trp polymorphism and glioma risk: an updated meta-analysis.
    Xu C; Chen P; Liu W; Gu AH; Wang XR
    Asian Pac J Cancer Prev; 2014; 15(17):7419-24. PubMed ID: 25227852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.
    Lu JT; Deng AP; Song J; Zhang L; Luo J
    Oncotarget; 2017 Mar; 8(13):21599-21608. PubMed ID: 28423490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: a meta-analysis.
    Xie T; Wang ZG; Zhang JL; Liu H
    World J Gastroenterol; 2012 Aug; 18(31):4207-14. PubMed ID: 22919255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis.
    Wu W; Liu L; Yin Z; Guan P; Li X; Zhou B
    PLoS One; 2014; 9(1):e86798. PubMed ID: 24497981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between X-ray cross-complementing group 1 polymorphisms and the onset risk of glioma: A meta-analysis.
    Gu X; Sun H; Chang L; Sun R; Yang H; Zhang X; Cong X
    Neural Regen Res; 2013 Sep; 8(26):2468-77. PubMed ID: 25206557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis of associations between XRCC1 gene polymorphisms and susceptibility to systemic lupus erythematosus and rheumatoid arthritis.
    Zhang MY; Yang XK; Lv TT; Wu J; Xu SZ; Wang JB; Pan HF; Ye DQ
    Int J Rheum Dis; 2018 Jan; 21(1):179-185. PubMed ID: 28198159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B; Shen T
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
    Li Y; Liu F; Tan SQ; Wang Y; Li SW
    PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.
    Zhang H; Liu H; Knauss JL
    Tumour Biol; 2013 Oct; 34(5):3003-13. PubMed ID: 23712607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
    He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
    PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
    Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
    PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
    Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
    Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis.
    Li S; Deng Y; You JP; Chen ZP; Peng QL; Huang XM; Lu QH; Huang XL; Zhao JM; Qin X
    Dig Dis Sci; 2013 Jul; 58(7):1880-90. PubMed ID: 23543084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Wang L; Yin F; Xu X; Hu X; Zhao D
    PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.